UK markets close in 6 hours

SpineGuard SA (ALSGD.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.4660+0.0160 (+3.56%)
As of 11:13AM CEST. Market open.
Full screen
Previous close0.4500
Open0.4502
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.4502 - 0.4700
52-week range0.4010 - 1.6740
Volume28,126
Avg. volume129,531
Market cap15.342M
Beta (5Y monthly)2.73
PE ratio (TTM)N/A
EPS (TTM)-0.0630
Earnings date13 Oct 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1.56
  • Business Wire

    SpineGuard Reports Third-quarter 2022 Revenue

    PARIS & BOULDER, Colo., October 04, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today that its revenue was € 1.5 M in the third quarter up 44% and € 4.0 M YTD up 24%.

  • Business Wire

    SpineGuard Reports Six-Month 2022 Financial Results

    PARIS & BOULDER, Colo., September 15, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today financial results for the half year ending June 30, 2022, as approved by the Board of Directors on September 15, 2022.

  • Business Wire

    Omnia Medical and SpineGuard Announce a Strategic Alliance for Adult Spine Surgery in the United States

    MORGANTOWN, W.Va. & BOULDER, Colo. & PARIS, September 12, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and Omnia Medical, a medical device company focused on innovative solutions utilizing proven techniques, announced today the signature of a co-development and exclusive distribution agreement for adult spine surgery in the United States